Inventor · disambiguated record
Dario Braga
Also filed as: BRAGA DARIO
22 granted patents·29 pending applications·504 citations·filing 2003–2022
97Inventor score
Top patents by PatentIndex Score
51 records- 0197US8158781B2Polymorphic forms α, β and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·27 cites·8 claims
- 0297US7902206B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 8, 2011·28 cites·57 claims
- 0397US7045620B2Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsALFA WASSERMANN SPA·Filed 2003·Granted May 16, 2006·139 cites·20 claims
- 0496US8835452B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Sep 16, 2014·15 cites·21 claims
- 0596US8193196B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2006·Granted Jun 5, 2012·40 cites·24 claims
- 0696US7906542B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 15, 2011·40 cites·25 claims
- 0795US8741904B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2013·Granted Jun 3, 2014·20 cites·44 claims
- 0895US8518949B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Granted Aug 27, 2013·25 cites·21 claims
- 0995US8158644B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·26 cites·20 claims
- 1095US7923553B2Processes for the production of polymorphic forms of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Apr 12, 2011·18 cites·46 claims
- 1195US7612199B2Polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2009·Granted Nov 3, 2009·45 cites·7 claims
- 1294US9271968B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2014·Granted Mar 1, 2016·14 cites·18 claims
- 1393US8853231B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Oct 7, 2014·15 cites·18 claims
- 1492US8173801B2Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted May 8, 2012·14 cites·19 claims
- 1591US9624192B2Carbamate/urea derivativesAUBERSON YVES·Filed 2016·Granted Apr 18, 2017·11 cites·20 claims
- 1687US9034874B2Carbamate/urea derivativesAUBERSON YVES·Filed 2013·Granted May 19, 2015·12 cites·20 claims
- 1782US9273026B2Carbamate/urea derivativesAUBERSON YVES·Filed 2015·Granted Mar 1, 2016·4 cites·24 claims
- 1880US8748447B2Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effectVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Jun 10, 2014·5 cites·12 claims
- 1980US2022119403A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 2080US2022127283A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 2177US9452157B2Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereofALFA WASSERMANN SPA·Filed 2013·Granted Sep 27, 2016·5 cites·34 claims
- 2273US10703763B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2019·Granted Jul 7, 2020·0 cites·9 claims
- 2373US2020339599A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2473US2019263829A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 2573US2020277301A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2673US2020339600A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2772US2015175627A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 2871US2019263830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 2970US9498442B2Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effectALFA WASSERMANN SPA·Filed 2014·Granted Nov 22, 2016·1 cites·7 claims
- 3070US2019135831A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 3168US2019135830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 3267US2018065987A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 3367US2008262024A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2008·Application pending·0 cites
- 3467US2015182508A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 3566US2018291032A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2017·Application pending·0 cites
- 3666US2012203000A1Polymorphic forms alpha, beta and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 3766US2017210758A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 3865US2018065988A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 3963US2017210757A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 4062US2012202989A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4161US2016362419A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 4258US2005272754A1Polymorphic forms of rifaximin, processes for their production and uses thereofALFA WASSERMANN SPA·Filed 2005·Application pending·0 cites
- 4357US2012258166A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4457US2022119410A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 4556US2012035202A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Application pending·0 cites
- 4654US2012214989A1Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4754US2011086871A1Rifaximin compositions and method of useALFA WASSERMANN SPA·Filed 2010·Application pending·0 cites
- 4854US2017275264A1Carbamate/urea derivativesAUBERSON YVES·Filed 2017·Application pending·0 cites
- 4949US7956042B2Crystalline forms of macrolide compounds endowed with antiinflammatory activityZAMBON SPA·Filed 2006·Granted Jun 7, 2011·0 cites·17 claims
- 5039US2017189385A1Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereofALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dario Braga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →